Corcept Therapeutics reported $32.2M in EBITDA for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebitda Change
Acadia Pharmaceuticals ACAD:US $ -42.78M 23.1M
Ani Pharmaceuticals ANIP:US $ 4.69M 9.3M
Aphria Inc APH:CN C$ -69699000 38.32M
Ardelyx ARDX:US $ -44.47M 12.88M
Aurora Cannabis Inc ACB:CN -86753000 52.4M
Biomarin Pharmaceutical BMRN:US $ 41.16M 14.24M
Bristol Myers Squibb BMY:US $ 5679M 455M
Canopy Growth Corp WEED:CN C$ -67550000 55.34M
Corcept Therapeutics CORT:US $ 32.2M 12.31M
Eleven Biotherapeutics EBIO:US $ -25.36M 29.83M
Eli Lilly And LLY:US $ 1797.7M 218.8M
Esperion Therapeutics ESPR:US $ -32380000 50.29M
Gw Pharmaceuticals GWPH:US $ -17.18M 2.02M
Johnson & Johnson JNJ:US $ 8192M 2043M
Knight Therapeutics Inc GUD:CN C$ 9.35M 4.46M
Lannett LCI:US $ 4.57M 7.98M
Nektar Therapeutics NKTR:US $ -106.66M 0.81M
Novartis NOVN:VX SF 4772M 423M
Novartis NVS:US $ 4772M 423M
Omeros OMER:US $ -23661000 6.56M
Pacira Pharmaceuticals PCRX:US $ 39.89M 13.68M
Pfizer PFE:US $ 7593M 610M
Supernus Pharmaceuticals SUPN:US $ 40.06M 20.24M
Ziopharm Oncology ZIOP:US $ -21.96M 0.94M